Calamos Advisors’s MDxHealth MDXH Stock Holding History

Calamos Advisors’s Portfolio MDXH Stock Details MDXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-67,452	Closed	-$241K	–	1243
2025 Q4	$241K	Buy	67,452 +1,949	+3%	+$7.7K	﹤0.01%	835
2025 Q3	$305K	Buy	+65,503	New	+$201K	﹤0.01%	810

Other funds holding MDXH

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Samjo Management New York $231M AUM 13.04% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Calamos Advisors's MDXH Position: Q1 2026 in Review

Calamos Advisors sold out of MDxHealth (MDXH) in Q1 2026, closing a stake of 67,452 shares — an estimated $241K sold.

Calamos Advisors first reported a position in MDXH in Q3 2025 and held it in 2 quarters. The position peaked at $305K in Q3 2025. 51 funds tracked by Wall St. Rank hold MDXH as of Q1 2026.

Calamos Advisors reported no remaining MDxHealth position as of Q1 2026 after selling out during the quarter.
Calamos Advisors sold 67,452 MDxHealth shares in Q1 2026, an estimated $241K.
Calamos Advisors first reported a position in MDxHealth in Q3 2025 and held it in 2 quarters.
Calamos Advisors's MDxHealth position peaked at $305K in Q3 2025.
51 funds tracked by Wall St. Rank held MDxHealth as of Q1 2026.

Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.